High blood pressure - these vitamin supplements will lower your risk of heart attacks
Vitamin D supplements could help to reverse damage to blood vessels after suffering from high blood pressure, scientists have revealed. Cardiovascular damage increases the risk of deadly cardiac arrhythmia. (Source: Daily Express - Health)
Source: Daily Express - Health - January 31, 2018 Category: Consumer Health News Source Type: news
Philips joins $9m round for remote-care co LindaCare
Digital health company LindaCare has landed an $8.7 million Series B round, with investments made by Philips (NYSE:PHG), PMV, Capricorn ICT Arkiv, Connecticut Innovations and others. The Belgium-based company said it plans to use the newly-acquired funds to accelerate its U.S. market expansion and product commercialization, as well as build out its existing patient monitoring software platform for a broader range of cardiac diseases. “This investment is a significant step for us, as it enables LindaCare to execute faster on our ambitious vision and strategy, and to take a leading market position across both...
Source: Mass Device - January 24, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Funding Roundup Patient Monitoring lindacare royalphilips Source Type: news
Cyclizine is sold in Denmark as an over-the-counter drug and has serious side effects when overdosed - Petersen K, Hjorth P.
Cyclizine is sold in Denmark as an over-the-counter drug and affects not only histaminergic but also muscarinergic, serotonergic and α-adrenergic receptors, with side effects such as respiratory depression and cardiac arrhythmias, leading to fatalities. D... (Source: SafetyLit)
Source: SafetyLit - January 18, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
The Startup Caf é, the Place where Healthcare IT Decision-Makers and New Companies can Meet
17 - 19 April 2018, Berlin, Germany. Whether they develop apps that detect the early stages of cardiac arrhythmia or cybersecurity software for hospitals, startups in the healthcare IT sector are flexible, highly innovative and can make a significant contribution to digitalising the healthcare system. (Source: eHealth News EU)
Source: eHealth News EU - January 16, 2018 Category: Information Technology Tags: Featured Events Conferences and Events Source Type: news
Abbott Expands Portfolio of MRI-Ready Devices
FDA gave MR-conditional labeling to two of Abbott's cardiac rhythm management (CRM) devices, a move that further boosts the company's ability to compete with its peers in the space. The Abbott Park, IL-based firm said patients who receive a Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D) or a Fortify Assura implantable cardioverter defibrillator (ICD) are now able to have an MRI in the future if need be. The Quadra Assura and the Fortify Assura are two of Abbott's most widely-used high voltage devices, the company noted. In September 2016, Abbott won FDA approval for MR-conditional labeling for the...
Source: MDDI - January 3, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Regulatory and Compliance Source Type: news
The 8th Annual Alexander Awards: The Best Tox Reading of 2017
Alexander Gettler Once again, last year’s outstanding examples of long-form journalism dealing with topics related to medical toxicology were dominated by coverage of the opioid crisis, its origins and the resulting carnage. The must-read article of the year was “The Family That Built a Empire of Pain,” Patrick Radden Keefe’s massive history of the Sacklers, one of America’s richest clans, much of whose wealth comes from their ownership of Purdue Pharma and the marketing and distribution of Oxycontin. The article, which appeared in the New Yorker, notes that the clan’s patriarch, Ar...
Source: The Poison Review - January 2, 2018 Category: Toxicology Authors: Leon Gussow Tags: Medical 2017 Alexander awards opioids Purdue Pharma Sackler Source Type: news
Researchers are developing light therapy as a non-invasive, alternative treatment for disease
(Natural News) Artificial light has both its risks and benefits, but a new study shows that it may be the solution to minimally invasive, drug-free treatments. Researchers are currently developing new ways using infrared neuromodulation to treat cardiac arrhythmia (irregular heart beat), hypertension (high blood pressure), asthma, sleep apnea (suspension of breathing during sleep), diarrhea, and... (Source: NaturalNews.com)
Source: NaturalNews.com - December 18, 2017 Category: Consumer Health News Source Type: news
Spinal Elements lifts former COO Blain to the corner office | Personnel Moves November 30, 2017
Spinal Elements, previously known as Amendia, said this week it is lifting co-founder and current prez & COO Jason Blain to the position of prez & CEO, effective immediately. Prior to coming on to co-found Spinal Elements, Blain served in various roles with medtech companies Smith & Nephew (NYSE:SNN), Alphatec (NSDQ:ATEC) and NuVasive Inc. (NSDQ:NUVA). Blain is replacing Chris Fair, who will stay on as a board member with the company. “I am excited by the opportunity to lead our talented team of employees and partners and create an even more vibrant and dynamic Spinal Elements in the years ...
Source: Mass Device - November 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Abbott Alphatec Apica Cardiovascular Bovie Medical Corp. Cardiovascular Systems Inc. Dentsply Sirona Guidant Corp. Lima Corporate Medical Device Innovation Consortium MedLumics MedTech Europe Medtronic Nuv Source Type: news
Shining a light on the nervous system to thwart disease
(Case Western Reserve University) Researchers from Case Western Reserve University School of Medicine, Vanderbilt University, and University of Pittsburgh have received a four-year, $9 million grant from the National Institutes of Health to develop enhanced infrared light technology (infrared neuromodulation) for potentially treating a variety of diseases, including cardiac arrhythmias, high and low blood pressure, asthma, sleep apnea and diarrhea, one of the leading killers of children worldwide. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2017 Category: International Medicine & Public Health Source Type: news
URMC Cardiologist Receives High Honor from American Heart Association
University of Rochester Medical Center cardiologist Arthur J. Moss, M.D., whose research on cardiac arrhythmias has saved countless lives and changed the treatment of heart disease worldwide, was honored with the 2017 James B. Herrick Award at the American Heart Association ’s Scientific Sessions. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - November 13, 2017 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news
Abbott Launches the First and Only Smartphone Compatible Insertable Cardiac Monitor in the U.S.
THE CONFIRM RX ICM COMBINES ADVANCED MEDICAL DEVICE WITH THE LATEST IN MOBILE AND DIGITAL TECHNOLOGY PHYSICIANS CAN REMOTELY MONITOR THEIR PATIENTS WITH CONFIRM RX FOR EVEN THE MOST DIFFICULT TO DETECT CARDIAC ARRHYTHMIAS, INCLUDING IRREGULAR HEARTBEATS... Devices, Monitoring, Cardiology, FDA, Product Launch Abbott, Confirm Rx, Insertable Cardiac Monitor, Cardiac Monitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 23, 2017 Category: Pharmaceuticals Source Type: news
Abbott wins FDA nod for Confirm Rx smartphone-connected cardiac monitor
Abbott (NYSE:ABT) said today it won FDA clearance for its Confirm Rx insertable cardiac monitor, touting it as the 1st and only smartphone compatible ICM designed to help identify cardiac arrhythmias. The Confirm Rx system includes a sensor designed to be implanted just under the skin over the chest in a minimally-invasive outpatient procedure, the company said. The newly cleared device features incorporated Bluetooth wireless technology to allow patients to connect to the device on their smartphone devices through Abbott’s myMerlin mobile application. Data collected by the device is also transmitted to the...
Source: Mass Device - October 23, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Food & Drug Administration (FDA) Patient Monitoring Regulatory/Compliance Abbott Source Type: news
Getting to the heart of mapping arrhythmia-related excitations
(American Institute of Physics) Atrial fibrillation is the most prevalent form of cardiac arrhythmia, affecting up to 6 million people in the US alone. Common treatments for severe forms of the erratic beating phenomenon are controversial, and guided by detection methods that are not yet standardized or fully refined. But research from a group of cross-disciplinary scientists, published this week in the journal Chaos, offers a computational approach to understanding the important factors involved in measuring cardiac excitation waves. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 29, 2017 Category: International Medicine & Public Health Source Type: news
Abbott Catches Up to Peers With MRI-Compatible ICD
Abbott Laboratories acquired St. Jude Medical earlier this year knowing that the company trailed behind its peers in the cardiac rhythm management (CRM) space by not having a MRI-compatible pacemaker or implantable cardioverter defibrillator (ICD) system. It seems Abbott has officially caught up in that category though, first with FDA approval of the Assurity MRI pacemaker and the Tendril MRI pacing lead during the first quarter, and now with FDA approval of MRI-conditional labeling for the Ellipse ICD system. Abbott said the recent approval covers one of its most widely-used ICD systems and associated high voltage leads. ...
Source: MDDI - September 23, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: MD & M Minneapolis Labeling Business Source Type: news
Abbott wins MR-conditional label for Ellipse ICDs
Abbott (NYSE:ABT) said today that it won an MR-conditional label from the FDA for the Ellipse implantable cardioverter defibrillator it acquired along with St. Jude Medical early this year. The MR-conditional label applies to Ellipse and the Tendril MRI pacing lead and the Durata and Optisure high-voltage leads, the Chicago-area medical device giant said. “When you consider the number of patients each year who rely on the lifesaving treatment delivered by an ICD device, it is critical to continually innovate to provide new benefits to people battling complex arrhythmias and other cardiac conditions,” cardiac ar...
Source: Mass Device - September 22, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Food & Drug Administration (FDA) Imaging Regulatory/Compliance Abbott Cardiac Rhythm Management Source Type: news
Is BioSig for Real This Time With Its Pure EP?
A couple years ago, BioSig Technologies, Inc. was poised to apply for FDA clearance to market its technology to improve treatment of atrial fibrillation and ventricular tachycardia. Then its scientific advisors advised the Minneapolis company to put more work into that technology, a hardware-software combination designed to present clearer signals during electrophysiology studies and catheter ablation. The technology, Pure EP, is designed to cut through the background noise of the lab and its equipment during cardiac recordings, enabling physicians to target and neutralize the areas of the heart that are causing atria...
Source: MDDI - September 7, 2017 Category: Medical Devices Authors: Nancy Crotti Tags: MD & M Minneapolis R Software Source Type: news
Abbott wins FDA nod for HeartMate 3 pump
Abbott (NYSE:ABT) said today that the FDA approved its HeartMate 3 implantable pump for heart failure patients awaiting a transplant. The approval is the latest for the HeartMate line of left ventricular assist devices first developed by Thoratec, which was later acquired by St. Jude Medical before a $25 billion merger brought it to Abbott earlier this year. Abbott said HeartMate 3 features full magnetic levitation for the pump’s impeller, aiming to cause less trauma to blood cells as they pass through the pump. Although it is smaller than its predecessor, Abbott claimed it has the industry’s largest ...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiac Assist Devices Food & Drug Administration (FDA) Abbott Source Type: news
Numerate receives NIH funding to discover new anti-arrhythmic treatments
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded a small business innovation research (SBIR) Phase I grant to Numerate to boost a new drug programme for cardiac arrhythmias. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 9, 2017 Category: Pharmaceuticals Source Type: news
Not all astrocytes in the brain are the same, study finds
From afar, the billions of stars in our galaxy look indistinguishable, just as the billions of star-shaped astrocytes in our brains appear the same as each other. But UCLA researchers have now revealed that astrocytes, a type of brain cell that supports and protects neurons, aren ’t all the same. While stars might be categorized by their size, age and heat, the supportive brain cells vary when it comes to shape, molecular machinery and functioning.The findings,published today in the journal Neuron, should make it easier for researchers to study how astrocytes relate to disease, or to develop drugs that aim...
Source: UCLA Newsroom: Health Sciences - July 13, 2017 Category: Universities & Medical Training Source Type: news
CathVision inks investment deal for electrophysiology system
Early-stage medical device company CathVision said today it inked a “multi-million venture investment” to support the development and marketing of its electrophysiology recording system designed for treating cardiac arrhythmia. The undisclosed investment came from Scandanavian-based VF Venture and Borean Innovation, Denmark-based CathVision said. “CathVision works in one of the fastest growing segments in medical technology. CathVision’s team has worked patiently and consistently with their product over a number of years, and we have followed the company for several years. I think CathVision represe...
Source: Mass Device - July 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular cathvision Source Type: news
Adverse Drug Event Causality Analysis (ADECA): a process for evaluating evidence and assigning drugs to risk categories for sudden death - Woosley RL, Romero K, Heise CW, Gallo T, Tate J, Woosley RD, Ward S.
Growing evidence indicates that many drugs have the ability to cause a potentially lethal cardiac arrhythmia, torsades de pointes (TdP). This necessitates the development of a compilation of drugs that have this potential toxicity. Such a list is helpful i... (Source: SafetyLit)
Source: SafetyLit - June 24, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Tenth year of data on cardiac arrhythmia treatment launched at European congress
(European Society of Cardiology) The tenth year of data on cardiac arrhythmia treatment is being launched at EHRA EUROPACE - CARDIOSTIM 2017. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 18, 2017 Category: International Medicine & Public Health Source Type: news
Medical News Today: Does the sound of airplanes raise blood pressure risk?
A new study investigates the effect of long-term exposure to aircraft noise on the risk of high blood pressure, cardiac arrhythmia, and stroke. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 14, 2017 Category: Consumer Health News Tags: Public Health Source Type: news
Lessons from Fire Prevention: Why We Can Head Off Disease Without Sacrificing Cure
This insightful and data-filled evidence-based article from the Boston University School of Public Health illustrates the work EMS can, and should, do to prevent disease where we cannot control curing it: Public health is concerned with creating a healthier world, preferably one where we prevent disease before it starts. This inevitably occasions grappling with our overwhelming investment in medicine and curative care, and arguing for a recalibration of our investment towards the social, economic, and cultural factors that promote health. We can educate people how to reduce their chances of suffering heart attacks, ...
Source: JEMS: Journal of Emergency Medical Services News - June 11, 2017 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT P Tags: Training News Source Type: news
Acute alcohol intoxication in an eight weeks old infant - Frenkel Rutenberg T, Benacun M.
INTRODUCTION: Alcohol intoxication in infants is a life-threatening condition which requires early diagnosis and treatment. It may lead to multi-system injury, including mental deterioration, respiratory depression, cardiac arrhythmia, metabolic disorders ... (Source: SafetyLit)
Source: SafetyLit - June 1, 2017 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Bathroom scales will inform about life threatening conditions
(Kaunas University of Technology) Weighing oneself has become one of the most common morning rituals. However, your weight is not the only message that can be delivered by your bathroom scales: the team of researchers at Kaunas University of Technology (KTU) Institute of Biomedical Engineering are developing the multifunctional scales, which can monitor your health and inform about potentially dangerous life conditions, such as arteriosclerosis or cardiac arrhythmia. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 16, 2017 Category: Biology Source Type: news
Arthur Moss Receives Heart Rhythm Society ’s Pioneer in Cardiac Pacing and EP Award
Arthur J. Moss, M.D., received the award for his dedication to understanding and treating electrical disturbances of the heart, including cardiac arrhythmias, sudden cardiac death, heart failure and Long QT syndrome. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - May 12, 2017 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news
Abbott wins CE Mark for new TactiCath ablation catheter
Abbott (NYSE:ABT) said today that the TactiCath sensor-enabled ablation catheter it bought along with St. Jude Medical (NYSE:STJ) this year won CE Mark approval in the European Union. The Chicago-area healthcare giant said the new TactiCath device can be integrated with another St. Jude product, the EnSite Precision heart mapping system it launched earlier this year. “The goal in developing the TactiCath contact force ablation catheter, sensor enabled, was to provide the most innovative solution for treating atrial fibrillation and lead the way in clinical outcomes for patients with cardiac arrhythmias &nda...
Source: Mass Device - May 9, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Catheters Regulatory/Compliance Wall Street Beat Abbott stjudemedical Source Type: news
Abbott wins CE Mark for Confirm Rx cardiac monitor
Abbott (NYSE:ABT) said today that its St. Jude Medical (NYSE:STJ) subsidiary won CE Mark approval in the European Union for the ConfirmRx insertable cardiac monitor, touting as the world’s 1st smartphone-compatible ICM. The continuous heart monitor is designed to work with St. Jude’s myMerlin mobile app to allow physicians to remotely follow patients and diagnose arrhythmias. Abbott said it’s on the market in 10 “select” countries in Europe, with a full release slated for the 2nd quarter. The FDA is also reviewing the device, the Chicago-area healthcare giant said. &l...
Source: Mass Device - May 8, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiovascular Patient Monitoring Regulatory/Compliance Abbott st-jude-medical Source Type: news
Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor
Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm RxTM Insertable Cardiac Monitor (ICM), the world's first smartphone compatible ICM that will help physicians identify difficult to detect cardiac arrhythmias, including atrial fibrillation (AF), to help guide therapy. Since CE Mark approval, adoption of the device has been strong and implants have occurred in 10 countries across Europe. (Source: eHealth News EU)
Source: eHealth News EU - May 8, 2017 Category: Information Technology Tags: Featured Industry Business and Industry Source Type: news
Abbott announces CE Mark and first use of the world's first smartphone compatible insertable cardiac monitor
Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm RxTM Insertable Cardiac Monitor (ICM), the world's first smartphone compatible ICM that will help physicians identify difficult to detect cardiac arrhythmias, including atrial fibrillation (AF), to help guide therapy. Since CE Mark approval, adoption of the device has been strong and implants have occurred in 10 countries across Europe. (Source: World Pharma News)
Source: World Pharma News - May 8, 2017 Category: Pharmaceuticals Tags: Featured Abbott Business and Industry Source Type: news
Digital health news briefs for 5/4/2017: CardioNet HIPAA settlement, Telemedicine lactation consulting
OCR settles HIPAA complaint with CardioNet. CardioNet, one of the oldest companies in the mobile cardiac arrhythmia monitoring space, has agreed to pay the Office of Civil Rights $2.5 million and enter into a corrective action plan in the end result of a HIPAA breach investigation that's been going on since 2012. (Source: mobihealthnews)
Source: mobihealthnews - May 4, 2017 Category: Information Technology Source Type: news
Advanced Cardiac Therapies lands $45m round led by new PE shop Ajax Health
Ajax Health, the medical device portfolio management company newly formed by KKR and Aisling Capital, led a $45 million round for Advanced Cardiac Therapeutics and the next-generation ablation catheter it’s developing. Earlier today the private equity giants launched tapped Spirox chairman & CEO Duke Rohlen to lead Ajax Health. Rohlen, the former president of FoxHollow Technologies and the founder & former chief executive of CV Ingenuity, is also CEO at ACT. That Santa Clara, Calif.-based company said existing backer New Enterprise Assoc. and new inv...
Source: Mass Device - May 2, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiovascular Catheters Funding Roundup Wall Street Beat Advanced Catheter Therapies ajaxhealth New Enterprise Associates questa Source Type: news
Binge drinking could trigger abnormal heart rhythms
Conclusion This cross-sectional study found binge drinking is associated with an increased risk of having an irregular heartbeat. However, the type of irregular heartbeat found was mainly sinus tachycardia, which isn't life threatening but involves the heart beating at an abnormally fast rate of over 100 heartbeats a minute. This research also has some notable limitations: The ECG recordings from the acute alcohol group were taken using a smartphone application operated outside the manufacturer's recommended environment. The lively atmosphere within the beer tent may have caused inaccurate recordings. The population...
Source: NHS News Feed - April 27, 2017 Category: Consumer Health News Tags: Heart/lungs Lifestyle/exercise Source Type: news
AliveCor raises $30m
AliveCor has raised $30.1 million in a new round of equity financing, according to an SEC filing posted this week. The Mountain View, Calif.-based company produces the Kardia mobile platform, which includes smartphone apps and accessories to allow for the monitoring of multiple vital signals. AliveCor’s monitoring app can record 5 vital statistics, the company said, including blood pressure, heart rhythm, resting heart rate, weight and physical activity. Money in the round comes from 9 unnamed investors, with the 1st sale in the round dated on March 15, according to the SEC filing. The company has not yet said how it...
Source: Mass Device - March 31, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Diagnostics mHealth (Mobile Health) AliveCor Source Type: news
Heart Societies update guidelines to support cardiac monitors for syncope patients
Medtronic (NYSE:MDT) said today that new guidelines from the American College of Cardiology, the American Heart Association and the Heart Rhythm Society now recommend the use of cardiac monitors for patients with syncope. The updated guidelines for patients with syncope, or unexplained fainting, was published online in the Journal of the American College of Cardiology, Circulation and HeartRhythm. Medtronic said that the new guidelines support the use of its Seeq MCT system, a wireless continuous external heart monitor that can be worn up to 30 days, and its Reveal Linq ICM with TruRhythm detection, an implantabl...
Source: Mass Device - March 24, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Patient Monitoring Medtronic Source Type: news
AliveCor raises $30m, launches Kardia Pro platform in U.S.
AliveCor said today that it landed $30 million in a series D funding round and that it released its artificial intelligence-enabled Kardia Pro platform in the U.S. The company’s platform enables doctors to remotely monitor their patients for early signs of atrial fibrillation, a common cardiac arrhythmia. “Heart disease is the No. 1 cause of death in the United States, claiming more lives than all forms of cancer combined. To manage heart disease and stroke risk, leading cardiologists want to see more than just ECGs from their patients,” CEO Vic Gundotra said in prepared remarks. “Kardia P...
Source: Mass Device - March 16, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Cardiovascular Funding Roundup Patient Monitoring Wall Street Beat AliveCor Source Type: news
Abbott announces FDA approval of Flexibility < sup > TM < /sup > Ablation Catheter, Sensor Enabled < sup > TM < /sup > to advance the treatment of complex cardiac arrhythmias
- Sensor EnabledTM tool complements the EnSite PrecisionTM cardiac mapping system and expands Abbott's comprehensive advanced cardiac mapping and ablation portfolio (Source: Abbott.com)
Source: Abbott.com - March 1, 2017 Category: Pharmaceuticals Source Type: news
Abbott wins FDA nod for FlexAbility sensor-enabled ablation cath
Abbott (NYSE:ABT) said today it won FDA approval for its sensor-enabled FlexAbility ablation catheter designed for cardiac ablation procedures to treat atrial flutter. The sensor-enabled FlexAbility ablation catheter is the Abbott Park, Ill.-based company’s 1st designed to collect electrical current resistance and magnetic data to produce accurate mapping and assist in treating sites that trigger or sustain abnormal heart rhythms. “I am seeing an increasing number of patients with complex cardiac arrhythmias, which has created a strong need for advanced tools that can meet the needs of those patients. Sensor En...
Source: Mass Device - March 1, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Catheters Food & Drug Administration (FDA) Regulatory/Compliance Abbott Source Type: news
Must-watch: video showing murder of Kim Jong Nam
Discussion on toxicology discussion boards have brought up the following possibilities: Tetramine: Tetramethylenedisulfotetramine (TETS) is a rat poison that has been banned since 1984 but which — according to Wikipedia — is still used in China. It is a white powder that is slightly soluble both in water and DMSO, a solvent that could accelerate dermal absorption. TETS is a neurotoxin that acts as a GABA antagonist causing refractory status epileptics, coma, and death. There is no specific antidote. Aconite: This plant poison is used in several Chinese herbal medicines.Aconite is a sodium channel opener, ...
Source: The Poison Review - February 22, 2017 Category: Toxicology Authors: Leon Gussow Tags: Medical assassination Kim Jong Nam Kuala Lumpur International Airport malaysia murder North Korea Source Type: news
Medtronic wins FDA clearance for CardioInsight 3D mapping tech
Medtronic (NYSE:MDT) said today that it won 510(k) clearance from the FDA for its CardioInsight Noninvasive 3D mapping system, which was designed to map irregular heart rhythms in the upper and lower chambers of the heart and provide electroanatomic 3D maps of the heart. The CardioInsight system is the 1st commercially available, noninvasive cardiac electrical mapping system in the world, according to Medtronic, and avoids the invasive steps of a traditional procedure to determine the origin of a patient’s irregular heart rhythm. Medtronic’s 3D cardiac mapping system employs a 252-electrode sensor vest, which i...
Source: Mass Device - February 1, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: 510(k) Cardiovascular Food & Drug Administration (FDA) Regulatory/Clearance Medtronic Source Type: news
Atrial fibrillation more prevalent in dialysis patients than expected
Atrial fibrillation, which is the most common cardiac arrhythmia, is an important risk factor for strokes. A multi-centre study shows that the prevalence of atrial fibrillation in haemodialysis patients in Vienna is significantly higher than previously thought. Moreover, only half of the patients affected are treated with an anticoagulant. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 16, 2017 Category: Science Source Type: news
Hypothermia Diagnosis and Treatment Could Save Lives
Hypothermia is a life threatening condition that may result in death. It is a drop in the core body temperature of less than 95°F (35° Celsius). This temperature is below what is required for normal metabolism and bodily function (Figure 1). The normal body temperature is between 97.7°F and 99.5°F (Fahrenheit) which is the same as 36.5°C and 37.5°C (Celsius). The body's thermoregulation mechanism adjusts to weather changes. Thermoregulation During extreme cold, the body receives a signal from sensory receptors. The signal will go up to the brain. The brain then sends a signal to the body to resp...
Source: Healthy Living - The Huffington Post - January 13, 2017 Category: Consumer Health News Source Type: news
Warmer Oceans Increase Likelihood Of Toxic Shellfish, Study Finds
The neurotoxin domoic acid inspired Alfred Hitchcock’s “The Birds” after hundreds of sooty shearwaters ingested the poison in the summer of 1961 and, well, lost their minds. The crazed birds likely consumed domoic acid via small fish like anchovies and sardines. It also tends to collect in shellfish, like clams, crabs and lobsters. And, according to a study published Tuesday in the Proceedings of the National Academy of Sciences, it may become more prevalent as oceans warm, threatening birds and humans alike. Researchers at Oregon State University, the University of Oregon, the National Oce...
Source: Science - The Huffington Post - January 11, 2017 Category: Science Source Type: news
Biotronik launches BioMonitor 2 subcutaneous heart monitor trial
Biotronik said today it enrolled the 1st patients in the BioInsight clinical study of its BioMonitor 2 heart monitor, which looks to investigate the feasibility implanting the BioMonitor 2 in office settings. The BioMonitor 2 device is designed for remote monitoring of patients with atrial fibrillation, syncope, bradycardia and tachychardia, Biotronik said. The device uses Biotronik’s ProMRI technology and is approved for full-body MRI scans at 1.5 and 3 tesla strength. “One of the benefits of BioMonitor 2 is the ease of the insertion procedure, which typically only takes a few minutes. In-office proc...
Source: Mass Device - December 5, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Clinical Trials Patient Monitoring Biotronik Source Type: news
Macrophage-dependent IL-1 & #946; production induces cardiac arrhythmias in diabetic mice
(D'Or Institute for Research and Education) One of the most serious complications of diabetes, heart arrhythmias, is now on its way to be prevented and combated. Heart problems are responsible for 65 percent of the deaths related to diabetes. This work confirms that the increase in blood glucose causes a specific inflammation, which directly affects the heart. Here the authors propose new therapeutic tools that are promising to treat the heart disease caused by diabetes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 24, 2016 Category: Global & Universal Source Type: news
UPDATE: Apama Medical raises $20m
Updated to include new information from Apama Medical Novel catheter ablation tech developer Apama Medical said it raised a total of $19.7 million, with $13.2 million coming from a closed Series C round and $6.5 million from a debt facility with Silicon Valley Bank. Apama Medical is developing novel ablation catheter technology to combine “the best elements of existing ablation technology while incorporating additional unique features to address gaps in current technology,” according to it’s website. The Series C round was joined by Ascension Ventures, Medvance Incubator Partners, ONSE...
Source: Mass Device - November 18, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Funding Roundup Wall Street Beat Apama Medical Source Type: news
Genetesis lands $1m seed round for CardioFlux heart imaging device
Genetesis said today that it raised a $1.2 million seed round for its CardioFlux heart imaging device. Cincinatti-based Genetesis said the round was led by CincyTech and Mark Cuban’s Radical Investments and included Loud Capital, Danmar Capital, Wilson Sonsini Investment Company, Genetesis management and private angels. The CardioFlux device is designed to create a 3D map to characterize the heart’s underlying electrical activity in patients with myocardial ischemia, atrial fibrillation, ventricular tachycardia and other cardiac arrhythmias. The company said it plans to use the pro...
Source: Mass Device - November 14, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiovascular Funding Roundup Imaging Genetesis Source Type: news
Japan approves St. Jude Medical ’ s EnSite, TactiCath
St. Jude Medical (NYSE:STJ) said today it won Japanese MHLW approval for its EnSite Precision cardiac mapping system and its TactiCath irrigated ablation catheter. The Ensite cardiac mapping system is designed for use in ablation procedures to visualize and aid in catheter navigation in the heart, providing detailed anatomical models and maps, St. Jude said. The system is designed to aid in diagnosing arrhythmias, guiding therapy and providing expanded procedural options. The St. Paul, Minn.-based company’s TactiCath quartz irrigated ablation catheter is designed for ablation procedures to treat atrial fibr...
Source: Mass Device - November 2, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Catheters Imaging Regulatory/Compliance St. Jude Medical Source Type: news
St. Jude launches EnSite Precision cardiac mapping system in EU
St. Jude Medical (NYSE:STJ) said today it fully launched its EnSite Precision cardiac mapping system and associated tools in Europe, expanding from an earlier limited release. The St. Paul, Minn.-based company touted more than 100 installations of the device across Europe so far, supporting more than 5,000 ablation procedures after a targeted release it expanded in April. “We collaborated with leading electrophysiologists to develop a cardiac mapping system that provides the automation, flexibility and precision needed during today’s ablation procedures. We are extremely pleased with how the physicians fro...
Source: Mass Device - October 5, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Imaging Regulatory/Compliance St. Jude Medical Source Type: news